Home » Topics » Regulatory » Patents

Patents
RSS

New NMDA NR2 receptor modulators synthesized at Aptinyx

Feb. 19, 2018

Bristol-Myers Squibb identifies novel Toll-like receptor 7/8/9 antagonists

Feb. 19, 2018

IOCB Prague and Palecky University Olomouc describe new anticancer nucleosides

Feb. 19, 2018

Bayer patents new menin/MLL interaction inhibitors

Feb. 19, 2018

Novel Toll-like receptor 2 antagonists discovered at Neuropore Therapies

Feb. 19, 2018

New isochroman derivatives presented by Sunovion Pharmaceuticals

Feb. 16, 2018

Pfizer patents novel C5a1 receptor antagonists

Feb. 16, 2018

Bristol-Myers Squibb Co. presents new TGFBR inhibitors

Feb. 16, 2018

Accro Bioscience divulges necrosis inhibitors

Feb. 16, 2018

Nodthera patents new NLRP3 inflammasome inhibitors

Feb. 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...